Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Square Stock Is Worth at Least $80 After Raising Guidance

By Chris Lau, InvestorPlace Contributor

Square lowered its Q2 outlook but raised its full-year 2019 guidance. Markets are still looking at the short-term for Square stock.

Dip in Shares of Aurora Cannabis Creates an Opportunity

By Chris Lau, InvestorPlace Contributor

Aurora Cannabis is falling as stock markets sell-off. Is the dip in ACB stock justified and is there an entry point from here?

Sprint Stock Price Now Depends on Entirely on T-Mobile Merger Terms

By Chris Lau, InvestorPlace Contributor

Sprint's volatility on the markets are due to uncertanties the merger with T-Mobile will close. Should investors hold either stock now?

Here’s Why Shares of General Electric Stock Are Worth at Least $10-$13

By Chris Lau, InvestorPlace Contributor

GE stock may trade in a range in the next few months as markets wait for General Electric to carry out its multi-year turnaround plan.

Should Intel Stock Be Bought on Weakness?

By Chris Lau, InvestorPlace Contributor

Intel has many challenges ahead, and Intel stock price has dropped meaningfully. Is INTC stock worth buying?

Load More